| Analysis | Metabolite Name | Measured Value | Units | Group | TIMEPOINT |
|---|---|---|---|---|---|
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.3367 | scaled units | High-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.3367 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.3367 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.3367 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.3367 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.3367 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.3367 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.3367 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.3367 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.3367 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.3367 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.3367 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.3367 | scaled units | Placebo | -0.5HR |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.3367 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.3367 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.3367 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.3367 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.3367 | scaled units | Placebo | BASELINE |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.3454 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.3772 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.3955 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.4002 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.4096 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.4151 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.4571 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.4593 | scaled units | Placebo | BASELINE |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.4744 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.4766 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.4816 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.4826 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.4827 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.4837 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.4892 | scaled units | High-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.4922 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.5063 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.5111 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.5148 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.5155 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.5181 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.5381 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.5510 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.5516 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.5634 | scaled units | High-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.5647 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.5653 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.5694 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.5795 | scaled units | Placebo | -0.5HR |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.5800 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.5881 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.6006 | scaled units | Placebo | -0.5HR |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.6132 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.6379 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.6396 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.6409 | scaled units | Placebo | -0.5HR |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.6438 | scaled units | High-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.6550 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.6883 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.6974 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.7166 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.7180 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.7201 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.7241 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.7331 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.7646 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.7870 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.7944 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.8020 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.8433 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.8506 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.8637 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.8901 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.9016 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.9145 | scaled units | High-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.9173 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.9372 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.9396 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.9483 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.9703 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.9891 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 0.9952 | scaled units | Placebo | -0.5HR |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 1.0000 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 1.0048 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 1.0071 | scaled units | High-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 1.0585 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 1.0874 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 1.0916 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 1.1071 | scaled units | Placebo | BASELINE |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 1.1127 | scaled units | High-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 1.1184 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 1.1195 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 1.1263 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 1.1701 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 1.1731 | scaled units | Placebo | -0.5HR |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 1.1770 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 1.1814 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 1.1821 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 1.1837 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 1.1941 | scaled units | Placebo | -0.5HR |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 1.2106 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 1.2132 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 1.2154 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 1.2268 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 1.2382 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 1.2390 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 1.2652 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 1.2698 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 1.2796 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 1.3101 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 1.3226 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 1.3477 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 1.3493 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 1.3590 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 1.3814 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 1.3931 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 1.4166 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 1.4324 | scaled units | Placebo | BASELINE |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 1.4385 | scaled units | Placebo | -0.5HR |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 1.4789 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 1.5198 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 1.5880 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 1.6405 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 1.6859 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 1.7077 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 1.7244 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 1.7321 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 1.7483 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 1.7874 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 1.8338 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 1.8533 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 1.8684 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 1.9144 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 1.9209 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 1.9379 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 1.9627 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 1.9832 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 2.0933 | scaled units | Placebo | BASELINE |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 2.1856 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 2.5424 | scaled units | Placebo | BASELINE |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 3.0565 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 3.4829 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 3.5291 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 3.7037 | scaled units | High-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 4.1038 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | 3-(3-hydroxyphenyl)propionate | 4.3823 | scaled units | High-Dose | +71HR POST INFUSION |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|